Susquehanna International Group
RNAC icon

Susquehanna International Group’s Cartesian Therapeutics RNAC Stock Holding History

Susquehanna International Group’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-42,900
Closed -$309K – 13969
2025
Q4 		$309K Sell
42,900
-24,700
-37% -$200K ﹤0.01% 9871
2025
Q3 		$691K Buy
67,600
+21,100
+45% +$237K ﹤0.01% 8227
2025
Q2 		$483K Buy
+46,500
New +$495K ﹤0.01% 9256
2022
Q4 		– Sell
-3,283
Closed -$162K – 13489
2022
Q3 		$162K Buy
+3,283
New +$180K ﹤0.01% 11134
2022
Q2 		– Sell
-1,073
Closed -$40K – 13796
2022
Q1 		$40K Sell
1,073
-924
-46% -$57.8K ﹤0.01% 12406
2021
Q4 		$195K Sell
1,997
-9,493
-83% -$1.02M ﹤0.01% 11477
2021
Q3 		$1.43M Buy
11,490
+1,647
+17% +$199K ﹤0.01% 6606
2021
Q2 		$1.23M Sell
9,843
-4,557
-32% -$543K ﹤0.01% 7163
2021
Q1 		$1.96M Buy
14,400
+13,390
+1,326% +$1.66M ﹤0.01% 5980
2020
Q4 		$92K Sell
1,010
-483
-32% -$41.9K ﹤0.01% 10533
2020
Q3 		$111K Buy
1,493
+243
+19% +$18.6K ﹤0.01% 9861
2020
Q2 		$107K Buy
1,250
+617
+97% +$55.9K ﹤0.01% 9462
2020
Q1 		$46K Buy
+633
New +$61.1K ﹤0.01% 9715
2019
Q4 		– Sell
-1,000
Closed -$53K – 10475
2019
Q3 		$53K Buy
+1,000
New +$53.1K ﹤0.01% 9761

Other funds holding RNAC

Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group's RNAC Position: Q4 2025 in Review

Susquehanna International Group sold out of Cartesian Therapeutics (RNAC) in Q4 2025, closing a stake of 12,330 shares — an estimated $99.7K sold.

Susquehanna International Group first reported a position in RNAC in Q1 2017 and held it in 21 quarters. The position peaked at $1.17M in Q1 2023. 67 funds tracked by Wall St. Rank hold RNAC as of Q4 2025.

  • Susquehanna International Group reported no remaining Cartesian Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Susquehanna International Group sold 12,330 Cartesian Therapeutics shares in Q4 2025, an estimated $99.7K.
  • Susquehanna International Group first reported a position in Cartesian Therapeutics in Q1 2017 and held it in 21 quarters.
  • Susquehanna International Group's Cartesian Therapeutics position peaked at $1.17M in Q1 2023.
  • 67 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.